IANNETTA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 6.513
AS - Asia 4.236
EU - Europa 2.671
SA - Sud America 649
Continente sconosciuto - Info sul continente non disponibili 597
AF - Africa 91
OC - Oceania 25
Totale 14.782
Nazione #
US - Stati Uniti d'America 6.317
SG - Singapore 1.989
IT - Italia 955
CN - Cina 628
BR - Brasile 530
HK - Hong Kong 496
RU - Federazione Russa 433
VN - Vietnam 350
BD - Bangladesh 291
IE - Irlanda 289
DE - Germania 196
FR - Francia 145
SE - Svezia 144
JP - Giappone 126
GB - Regno Unito 121
CA - Canada 101
FI - Finlandia 85
IN - India 83
NL - Olanda 82
ID - Indonesia 51
AT - Austria 49
AR - Argentina 45
MX - Messico 43
TR - Turchia 43
PL - Polonia 41
ES - Italia 34
IQ - Iraq 32
ZA - Sudafrica 28
KR - Corea 26
AU - Australia 24
EC - Ecuador 19
PK - Pakistan 19
CO - Colombia 18
IR - Iran 14
JM - Giamaica 14
PH - Filippine 12
VE - Venezuela 11
BE - Belgio 10
CL - Cile 10
CZ - Repubblica Ceca 10
EG - Egitto 10
KE - Kenya 10
LT - Lituania 10
MA - Marocco 10
UA - Ucraina 10
CH - Svizzera 9
PY - Paraguay 9
SA - Arabia Saudita 9
JO - Giordania 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
GR - Grecia 7
IL - Israele 7
MY - Malesia 7
NG - Nigeria 6
UZ - Uzbekistan 6
GT - Guatemala 5
HN - Honduras 5
KG - Kirghizistan 5
PE - Perù 5
RO - Romania 5
AZ - Azerbaigian 4
BB - Barbados 4
CR - Costa Rica 4
DK - Danimarca 4
EU - Europa 4
GH - Ghana 4
HU - Ungheria 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HR - Croazia 3
LV - Lettonia 3
MK - Macedonia 3
NI - Nicaragua 3
SC - Seychelles 3
SI - Slovenia 3
TW - Taiwan 3
AL - Albania 2
BG - Bulgaria 2
ET - Etiopia 2
LC - Santa Lucia 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BN - Brunei Darussalam 1
Totale 14.178
Città #
Singapore 1.037
San Jose 772
Hong Kong 487
Ashburn 478
Fairfield 359
Council Bluffs 326
Wilmington 299
Rome 287
Beijing 264
Chandler 261
Houston 223
Dublin 220
New York 191
Los Angeles 177
Santa Clara 162
Medford 150
The Dalles 138
Woodbridge 136
Tokyo 125
Ho Chi Minh City 124
Seattle 122
Cambridge 118
Buffalo 95
Ann Arbor 80
Hanoi 71
Lawrence 69
Lauterbourg 65
Milan 65
Dallas 62
Moscow 61
Helsinki 55
Nuremberg 54
San Diego 50
Chicago 49
Munich 47
São Paulo 42
Frankfurt am Main 41
Toronto 34
North Bergen 33
Orem 33
Naples 32
London 30
Jakarta 29
Lappeenranta 26
Atlanta 25
Brooklyn 25
Seoul 25
Rio de Janeiro 22
Warsaw 22
Chennai 21
Menlo Park 21
Montreal 21
Curitiba 20
Da Nang 20
Phoenix 20
Mexico City 18
Amsterdam 17
Denver 17
Engelhard 17
Salt Lake City 17
Stockholm 17
Boardman 15
Vienna 15
Ankara 14
Colorado Springs 14
San Francisco 14
Tampa 14
Bologna 13
Haiphong 13
Johannesburg 13
Philadelphia 13
Falls Church 12
Istanbul 12
Manchester 12
Palo Alto 12
Adelaide 11
Kilburn 11
Miami 11
Mumbai 11
Belo Horizonte 10
Brussels 10
Elk Grove Village 10
Las Vegas 10
Paris 10
Redondo Beach 10
Boston 9
Guangzhou 9
Kingston 9
Newark 9
Queens 9
Quito 9
Shanghai 9
Sydney 9
Umuarama 9
Washington 9
Biên Hòa 8
Chandigarh 8
Charlotte 8
Detroit 8
Florence 8
Totale 8.344
Nome #
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 408
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis 324
Depressive and anxiety symptoms in patients with SARS-CoV2 infection 217
P-375. Long-Term Suppressive Antimicrobial Therapy in Prosthetic Vascular Graft Infection: a Five-Year Retrospective Evaluation 193
Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection 191
Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients 187
Mild clinical manifestations of SARS-CoV-2 related pneumonia in two patients with multiple sclerosis under treatment with ocrelizumab 187
Cryptic HBV replicative activity is frequently revealed in anti-HBC-positive/hbsag-negative patients with HIV infection by highly sensitive molecular assays, and can be predicted by integrating classical and novel serological HBV markers 175
Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study 175
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 164
Long-term SARS-CoV-2 infection associated with viral dissemination in different body fluids Including bile in two patients with acute cholecystitis 162
Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity 160
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing 157
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications 149
T-cell responses to SARS-CoV-2 in Multiple Sclerosis patients treated with ocrelizumab healed from COVID-19 with absent or low anti-Spike antibody titers 148
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 147
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production 138
Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study) 138
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study 138
In patients with severe COVID-19, the profound decrease in the peripheral Bblood T-cell subsets is correlated with an increase of QuantiFERON-TB Gold Plus indeterminate rates and reflecting a reduced interferon-gamma production 136
Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients 134
High CD169 monocyte/lymphocyte ratio reflects immunophenotype disruption and oxygen need in COVID-19 patients 132
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 128
Persistence of circulating CD169+monocytes and HLA-DR downregulation underline the immune response impairment in PASC individuals: the potential contribution of different COVID-19 pandemic waves 126
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 124
Human Arboviral Infections in Italy: Past, Current, and Future Challenges 124
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae 122
Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection 120
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon 118
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients 115
Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017 114
Brain abscess caused by Actinomyces turicensis in a non-immunocompromised adult patient: a case report and systematic review of the literature 113
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment 113
Blood myeloid dendritic cells and slanDC in antiretroviral therapy-Suppressed HIV-infected patients 111
Archetype and rearranged non-coding control regions in urothelial bladder carcinoma of immunocompetent individuals 111
Circulation of sars-cov-2 variants in central Italy: spike variability characterization by deep-sequencing. 110
Conventional Dendritic Cells and Slan+ Monocytes During HIV-2 Infection 110
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 109
Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical hiv-associated atherosclerosis 108
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 108
Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells 106
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection 106
High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients 106
The Omicron Variant Is Associated with a Reduced Risk of the Post COVID-19 Condition and Its Main Phenotypes Compared to the Wild-Type Virus: Results from the EuCARE-POSTCOVID-19 Study 105
T Lymphocyte Subset Counts and Interferon-Gamma Production in Adults and Children with COVID-19: A Narrative Review 105
Natalizumab affects T-Cell phenotype in multiple sclerosis: Implications for JCV reactivation 105
ZIKV infection induces an inflammatory response but fails to activate types I, II, and III IFN response in human PBMC 105
Role of sonication in the microbiological diagnosis of implant-associated infections: beyond the orthopedic prosthesis 105
Remdesivir Influence on SARS-CoV-2 RNA Viral Load Kinetics in Nasopharyngeal Swab Specimens of COVID-19 Hospitalized Patients: A Real-Life Experience 104
Histoplasmosis in patients living with HIV in Europe: review of literature 104
Prevalence of hepatitis D virus infection in Central Italy has remained stable across the last 2 decades with dominance of subgenotypes 1 and characterized by elevated viral replication 103
Altered antigen-presenting cells during HIV-1 infection 103
Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort 102
Cell-associated {HIV} cross-presentation by plasmacytoid dendritic cells is potentiated by noncognate {CD}8$mathplus$ T cell preactivation 101
The Impact of Viral and Bacterial Co-Infections and Home Antibiotic Treatment in SARS-CoV-2 Hospitalized Patients at the Policlinico Tor Vergata Hospital, Rome, Italy 100
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus 100
In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-γ T cell response 100
HUMAN ENDOGENOUS RETROVIRUSES EXPRESSION CORRELATES WITH HIV RESERVOIR, LYMPHOCYTES ACTIVATION AND LOW CD4 COUNT IN VIROLOGICALLY SUPPRESSED PATIENTS 99
Low testosterone levels and high estradiol to testosterone ratio are associated with hyperinflammatory state and mortality in hospitalized men with COVID-19 (vol 25, pg 5889, 2021) 99
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens 98
An in-depth characterization of VOCs circulation by using NGS analysis of the Spike protein. 97
Imported severe malaria and risk factors for intensive care: A single-centre retrospective analysis 97
Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19 96
Infectious risk in multiple sclerosis patients treated with disease-modifying therapies: a three-year observational cohort study 96
Case report: Delayed diagnosis of congenital malaria by plasmodium vivax in a newborn of an Eritrean woman with varicella infection 95
Severe Plasmodium ovale malaria complicated by acute respiratory distress syndrome in a young Caucasian man 95
HIV-associated progressive multifocal leukoencephalopathy: Longitudinal study of JC virus non-coding control region rearrangements and host immunity 95
Viral Hemorrhagic Fevers Other than Ebola and Lassa 94
Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study 93
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication 93
Hiv-2 infection in a migrant from gambia: The history of the disease combined with phylogenetic analysis revealed the real source of infection 93
Unexpected human cases of cutaneous anthrax in Latium region, Italy, August 2017: integrated human-animal investigation of epidemiological, clinical, microbiological and ecological factors 93
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection 92
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy 91
An In-Depth Characterization of SARS-CoV-2 Omicron Lineages and Clinical Presentation in Adult Population Distinguished by Immune Status 90
In vivo release of alpha-defensins in plasma, neutrophils and CD8 T-lymphocytes of patients with HIV infection 90
Humoral Response after Two Doses of BNT162b2 mRNA Vaccine Has a Role in Predicting Response after Three Doses That Is Related to Plasma HIV Viremia and Nadir CD4+ Cell Count in HIV-Positive Patients 89
Severe bloodstream infection due to KPC-producer e coli in a renal transplant recipient treated with the double-carbapenem regimen and analysis of in vitro synergy testing a case report 88
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection. 88
HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA After Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort 88
The evolving landscape of COVID-19: Factors associated with in-hospital COVID-19 related mortality during the 2023-2024 phase of JN.1 subvariant dominance 86
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections 86
Sustained Remission in Relapsed/Refractory Diffuse Large B Cell Lymphoma Following Glofitamab Discontinuation Due to JC Virus Reactivation: Balancing Efficacy and Infectious Risk 85
Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome 85
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin 84
HIV-associated progressive multifocal leukoencephalopathy: Current perspectives 84
JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis 84
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. 84
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. 83
Diagnostic value of JC polyomavirus viruria, viremia, serostatus and microRNA expression in multiple sclerosis patients undergoing immunosuppressive treatment 83
Pacemaker lead endocarditis due to multidrug-resistant Corynebacterium striatum detected with sonication of the device 83
Hepatitis B-related hepatic flare during immune reconstitution syndrome after antiretroviral treatment initiation in an HBV surface antigen-positive patient with HIV: viroimmunological and histological characterization 82
Thymosin alpha 1 restores the immune homeostasis in lymphocytes during Post-Acute sequelae of SARS-CoV-2 infection 82
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses 82
Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, january 2018 82
NMR-based metabolomic approach to study urine samples of chronic inflammatory rheumatic disease patients 81
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. 80
Real-life Data on Cefiderocol Efficacy and Safety to Treat Multidrug-Resistant Acinetobacter baumannii Infections 80
Increased sCD163 and sCD14 Plasmatic Levels and Depletion of Peripheral Blood Pro-Inflammatory Monocytes, Myeloid and Plasmacytoid Dendritic Cells in Patients With Severe COVID-19 Pneumonia 80
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. 79
Totale 11.608
Categoria #
all - tutte 75.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022764 0 0 55 128 8 77 58 70 63 58 33 214
2022/2023845 84 44 51 62 75 214 92 64 65 12 42 40
2023/2024643 64 22 58 88 43 102 29 44 14 71 23 85
2024/20253.252 72 571 396 193 55 183 334 167 308 431 251 291
2025/20266.490 638 255 604 520 515 260 788 717 797 515 480 401
2026/20271.192 503 396 293 0 0 0 0 0 0 0 0 0
Totale 14.782